Personalized Gene Therapy Treatments for Cancer Market Growth Accelerated by Emergence of Novel Therapies


 Personalized gene therapy treatments involve altering genes to treat cancer. These treatments directly modify genes or insert new genes to treat or prevent cancer. They work by delivering healthy genes to replace the function of genes that are mutated or missing in cancer cells. Gene therapies help boost the immune system's ability to fight cancer and make chemotherapy more effective with fewer side effects. The global Personalized Gene Therapy Treatments for Cancer Market is estimated to be valued at US$ 2 Billion in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023-2028, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The emergence of novel therapies has accelerated growth in the personalized gene therapy treatments for cancer market. Researchers are developing novel gene therapy approaches that leverage gene editing technologies like CRISPR to target specific cancer-causing mutations or to stimulate anti-tumor activity. For instance, CRISPR Therapeutics is developing CTX130, an investigational allogeneic CAR-T cell therapy targeting CD70 for the treatment of both solid tumors and hematologic malignancies. Editas Medicine is also evaluating EDIT-101 for the treatment of Leber congenital amaurosis type 10 (LCA10), a rare genetic illness that leads to vision loss. These novel therapies offer more targeted and personalized treatment options, driving increased demand in the market.

Segment Analysis
The global personalized gene therapy treatments for cancer market is dominated by gene therapy treatments for lung cancer currently. Lung cancer accounts for the highest number of cancer related deaths annually across the globe. Gene therapy treatments aim to replace the defective genes or add new genes in lung cancer patients to make the immune cells stronger in fighting the cancer cells. These therapies are showing promising results in reducing tumor size and improving the prognosis of late stage lung cancer patients.

Key Takeaways
The global personalized gene therapy treatments for cancer market is expected to witness high growth over the coming years.

Regional analysis: North America dominates the global personalized gene therapy treatments for cancer market currently due to heavy investments in oncology research by biopharma companies in the region. The U.S. accounts for the highest research and development activities as well as clinical trials for personalized gene therapy treatments for cancer. Asia Pacific is anticipated to emerge as the fastest growing regional market over the forecast period supported by rising healthcare investments, growing cancer incidence, and increasing awareness about advanced treatment types in the region.

Key players: Key players operating in the personalized gene therapy treatments for cancer market are Gilead Sciences, Inc., Spark Therapeutics, Inc., bluebird bio, Inc., Juno Therapeutics, Editas Medicine, and Cellectis. Gilead Sciences has the highest market share for its Yescarta and Tecartus therapies approved for hematological cancers. Spark Therapeutics aims to aggressively expand itsgene therapy portfolio beyond retinal disorders into other disease areas includingoncology.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more